Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets

American Journal of Respiratory and Critical Care Medicine

Volumn 166, Issue 10, 2002, Pages 1375-1381

  Goldstein, Ivan ^a,b   Wallet, Frederic ^a,b   Nicolas Robin, Armelle ^a,b   Ferrari, Fabio ^a,b   Marquette, Charles Hugo ^a,b   Rouby, Jean Jacques ^a,b,c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

^c Réanimation Chirurgicale Pierre Viars Department of Anesthesiology 47 83 Boulevard de l'Hôpital ^*  (France)

Author keywords

Aerosols; Aminoglycosides; Bronchopneumonia; Mechanical ventilation; Piglets

Indexed keywords

AMIKACIN;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; ESCHERICHIA COLI; NEBULIZATION; NONHUMAN; PRIORITY JOURNAL; SWINE;

EID: 0037111134     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200204-363OC     Document Type: Article

References (37)

1. Markowicz P, Wolff M, Djedaini K, Cohen Y, Chastre J, Delclaux C, Merrer J, Herman B, Veber B, Fontaine A, et al. Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome: Incidence, prognosis, and risk factors: ARDS Study Group. Am J Respir Crit Care Med 2000;161:1942-1948.
2. Rubinstein E, Green M, Modan M, Amit P, Bernstein L, Rubinstein A. The effects of nosocomial infections on the length and costs of hospital stay. J Antimicrob Chemother 1982;9(Suppl A):93-100.
3. Cavallo JD, Leblanc F, Fabre R. Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study. Pathol Biol (Paris) 2000;48:472-477.
4. Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy: Importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 1987;155:93-99.
5. Garraffo R, Drugeon HB, Dellamonica P, Bernard E, Lapalus P. Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity. Antimicrob Agents Chemother 1990;34:614-621.
6. Rouby JJ, Poete P, Martin de Lassale E, Nicolas MH, Bodin L, Jarlier V, Korinek AM, Viars P. Prevention of gram negative nosocomial bronchopneumonia by intratracheal colistin in critically ill patients: Histologic and bacteriologic study. Intensive Care Med 1994;20:187-192.
7. Goldstein I, Wallet F, Robert J, Becquemin MH, Marquette CH, Rouby JJ. Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs. Am J Respir Crit Care Med 2002;165:171-175.
8. Rouby JJ, Martin De Lassale E, Poete P, Nicolas MH, Bodin L, Jarlier V, Le Charpentier Y, Grosset J, Viars P. Nosocomial bronchopneumonia in the critically ill: Histologic and bacteriologic aspects. Am Rev Respir Dis 1992;146:1059-1066.
9. Rouby JJ, Rossignon MD, Nicolas MH, Martin de Lassale E, Cristin S, Grosset J, Viars P. A prospective study of protected bronchoalveolar lavage in the diagnosis of nosocomial pneumonia. Anesthesiology 1989;71:679-685.
10. Fabregas N, Torres A, El-Ebiary M, Ramirez J, Hernandez C, Gonzalez J, de la Bellacasa JP, de Anta J, Rodriguez-Roisin R. Histopathologic and microbiologic aspects of ventilator-associated pneumonia. Anesthesiology 1996;84:760-771.
11. Marquette CH, Wermert D, Wallet F, Copin MC, Tonnel AB. Characterization of an animal model of ventilator-acquired pneumonia. Chest 1999;115:200-209.
12. Wermert D, Marquette CH, Copin MC, Wallet F, Fraticelli A, Ramon P, Tonnel AB. Influence of pulmonary bacteriology and histology on the yield of diagnostic procedures in ventilator-acquired pneumonia. Am J Respir Crit Care Med 1998;158:139-147.
13. Goldstein I, Bughalo MT, Marquette CH, Lenaour G, Lu Q, Rouby JJ. Mechanical ventilation-induced air-space enlargement during experimental pneumonia in piglets. Am J Respir Crit Care Med 2001;163:958-964.
14. Lu Q, Viera S. Richecoeur J, Puybasset L, Kalfon P, Coriat P, Rouby J. A simple automated method for measuring pressure-volume curves during mechanical ventilation. Am J Respir Crit Care Med 1999;159:275-282.
15. Dahlberg E. Estimation of the blood contamination of tissue extracts. Anal Biochem 1983;130:108-113.
16. Baselski VS, el-Torky M, Coalson JJ, Griffin JP. The standardization of criteria for processing and interpreting laboratory specimens in patients with suspected ventilator-associated pneumonia. Chest 1992;102(5 Suppl 1):571S-579S.
17. Baselski VS, Wunderink RG. Bronchoscopic diagnosis of pneumonia. Clin Microbiol Rev 1994;7:533-558.
18. Gibaldi M, Perrier D. Pharmacokinetics, 2nd ed. New York: Marcel Dekker; 1982.
19. Dhand R, Tobin MJ. Inhaled bronchodilator therapy in mechanically ventilated patients. Am J Respir Crit Care Med 1997;156:3-10.
20. Harvey CJ, O'Doherty MJ, Page CJ, Thomas SH, Nunan TO, Treacher DF. Comparison of jet and ultrasonic nebulizer pulmonary aerosol deposition during mechanical ventilation. Eur Respir J 1997;10:905-909.
21. Thomas SH, O'Doherty MJ, Page CJ, Treacher DF, Nunan TO. Delivery of ultrasonic nebulized aerosols to a lung model during mechanical ventilation. Am Rev Respir Dis 1993;148:872-877.
22. O'Riordan TG, Greco MJ, Perry RJ, Smaldone GC. Nebulizer function during mechanical ventilation. Am Rev Respir Dis 1992;145:1117-1122.
23. Goode ML, Fink JB, Dhand R, Tobin MJ. Improvement in aerosol delivery with helium-oxygen mixtures during mechanical ventilation. Am J Respir Crit Care Med 2001;163:109-114.
24. Jones RN, Croco MA, Kugler KC, Pfaller MA, Beach ML. Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Diagn Microbiol Infect Dis 2000;37:115-125.
25. Klastersky J, Carpentier-Meunier F, Kahan-Coppens L, Thys JP. Endotracheally administered antibiotics for gram-negative bronchopneumonia. Chest 1979;75:586-591.
26. Palmer LB, Smaldone GC, Simon SR, O'Riordan TG, Cuccia A. Aerosolized antibiotics in mechanically ventilated patients: Delivery and response. Crit Care Med 1998;26:31-39.
27. Bressolle F, de la Coussaye JE, Ayoub R, Fabre D, Gomeni R, Saissi G, Eledjam JJ, Galtier M. Endotracheal and aerosol administrations of ceftazidime in patients with nosocomial pneumonia: Pharmacokinetics and absolute bioavailability. Antimicrob Agents Chemother 1992;36:1404-1411.
28. Carcas AJ, Garcia-Satue JL, Zapater P, Frias-Iniesta J. Tobramycin penetration into epithelial lining fluid of patients with pneumonia. Clin Pharmacol Ther 1999;65:245-250.
29. Elman M, Goldstein I, Marquette CH, Wallet F, Lenaour G, Rouby JJ. Influence of lung aeration on pulmonary concentrations of nebulized and intravenous amikacin in ventilated piglets with severe bronchopneumonia. Anesthesiology 2002;97:199-206.
30. Matthay MA. Function of the alveolar epithelial barrier under pathologic conditions. Chest 1994;105(3 Suppl):67S-74S.
31. Lipworth BJ. Pharmacokinetics of inhaled drugs. Br J Clin Pharmacol 1996;42:697-705.
32. Dequin PF, Faurisson F, Lemarie E, Delatour F, Marchand S, Valat C, Boissinot E, de Gialluly C, Diot P. Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis. Eur Respir J 2001;18:316-322.
33. Cooney GF, Lum BL, Tomaselli M, Fiel SB. Absolute bioavailability and absorption characteristics of aerosolized tobramycin in adults with cystic fibrosis. J Clin Pharmacol 1994;34:255-259.
34. Pennington JE. Penetration of antibiotics into respiratory secretions. Rev Infect Dis 1981;3:67-73.
35. Santre C, Georges H, Jacquier JM, Leroy O, Beuscart C, Buguin D, Beaucaire G. Amikacin levels in bronchial secretions of 10 pneumonia patients with respiratory support treated once daily versus twice daily. Antimicrob Agents Chemother 1995;39:264-267.
36. Makhoul IR, Merzbach D, Lichtig C, Berant M. Antibiotic treatment of experimental Pseudomonas aeruginosa pneumonia in guinea pigs: Comparison of aerosol and systemic administration. J Infect Dis 1993;168:1296-1299.
37. Berendt RF, Long GG, Walker JS. Treatment of respiratory Klebsiella pneumoniae infection in mice with aerosols of kanamycin. Antimicrob Agents Chemother 1975;8:585-590.